What is the appropriate dose of furosemide (Lasix) for treating peripheral edema of the feet and ankles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Furosemide Dosing for Peripheral Edema of Feet and Ankles

For peripheral edema of the feet and ankles, start furosemide at 20-40 mg once daily, which can be increased by 20-40 mg increments every 6-8 hours as needed, up to a maximum of 600 mg/day, though most patients respond to doses well below this maximum. 1

Initial Dosing Strategy

The FDA-approved starting dose is 20-80 mg as a single dose 1. However, for straightforward peripheral edema without heart failure or cirrhosis, beginning at the lower end (20-40 mg) is most appropriate. If you don't see adequate diuresis within 6-8 hours, you can give the same dose again or increase by 20-40 mg increments 1.

Dose Titration

  • Timing: Wait at least 6-8 hours between dose adjustments 1
  • Increments: Increase by 20-40 mg steps 1
  • Frequency: Once adequate response is achieved, give once or twice daily (e.g., 8 AM and 2 PM) 1
  • Maximum: Up to 600 mg/day for severe edematous states, though this requires close monitoring 1

Context-Specific Considerations

Heart Failure Patients

For heart failure with congestion, the ACC/AHA guidelines recommend starting at 20-40 mg once or twice daily, with a maximum of 600 mg/day 2. The 2009 guidelines specify an initial IV dose of 40 mg with a maximum single dose of 160-200 mg 3.

Cirrhosis with Peripheral Edema

In cirrhotic patients, furosemide should not be used alone. Start with spironolactone 50-100 mg/day first, then add furosemide 20-40 mg/day only if needed, increasing to a maximum of 160 mg/day 4. The key difference here is that peripheral edema in cirrhosis allows for more aggressive weight loss (no daily limit) compared to ascites alone (0.5 kg/day maximum) 4.

Pediatric Dosing

For children, start at 2 mg/kg as a single dose, increasing by 1-2 mg/kg increments (no sooner than 6-8 hours apart), with a maximum of 6 mg/kg/day 1.

Important Clinical Pitfalls

Twice-daily dosing is more effective than once-daily for sustained diuresis, despite furosemide's common prescription as a single daily dose 5. The drug's short duration of action (6-8 hours) means once-daily dosing may allow sodium retention during the remaining hours 1, 5.

Monitor electrolytes closely, particularly within the first week and after any dose increase. Furosemide causes potassium and magnesium depletion, which increases arrhythmia risk 3. If the patient is on an ACE inhibitor or aldosterone antagonist, potassium supplementation is usually unnecessary and potentially dangerous 3.

Combine with sodium restriction (less than 2-5 g/day) to enhance effectiveness 4. Without dietary sodium restriction, even high doses may be ineffective 3.

When Standard Dosing Fails

If doses exceeding 80-120 mg are ineffective:

  • Switch to twice-daily dosing rather than increasing the single dose 1, 5
  • Consider torsemide (better bioavailability, longer duration) at one-quarter the furosemide dose 4, 6
  • Add a thiazide diuretic (e.g., metolazone 2.5-5 mg) for sequential nephron blockade 3
  • For severe resistance, IV continuous infusion (40 mg load, then 10-40 mg/hour) is superior to boluses 7, 3, 8

Monitoring Requirements

Check within 7 days of initiation or dose change:

  • Serum creatinine
  • Sodium (stop if <120-125 mmol/L) 9
  • Potassium (stop if <3 mmol/L) 9
  • Blood pressure
  • Daily weights

Stop furosemide immediately if severe hyponatremia, acute kidney injury, or symptomatic hypotension develops 9.

References

Research

Torsemide as a Primary Choice in Edema Associated with Heart Failure.

The Journal of the Association of Physicians of India, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.